Literature DB >> 7909339

Estradiol inhibition of arterial neointimal hyperplasia after balloon injury.

M L Foegh1, S Asotra, M H Howell, P W Ramwell.   

Abstract

PURPOSE: Estrogens have been shown to protect against cardiovascular disease in postmenopausal women. The mechanisms are unknown. In this study we investigated the effect of estrogen treatment on arterial neointimal proliferation elicited by balloon injury of blood vessels of the rabbit.
METHODS: The aorta and the common and external iliac arteries of the rabbit underwent balloon injury. 17-beta-Estradiol cypionate (100 micrograms/kg/day intramuscularly) was administered beginning 1 day before injury and until sacrifice at 22 to 24 days after injury. Angiopeptin (20 micrograms/kg/day) was administered for the same length of time as estrogen to a group of rabbits to use this peptide as a positive control for morphometric analysis. Angiopeptin was also combined with estradiol to determine whether it was possible to further enhance the effect of estrogen. Morphometric studies were performed to determine measurement of intimal thickening. Inhibition of cell proliferation by estrogen was evaluated by incorporation of tritiated thymidine in vitro into the balloon injured rabbit aorta 72 hours after balloon injury.
RESULTS: Treatment of male rabbits with estradiol significantly (p < 0.01) decreased the neointimal thickening of these vessels by 50% to 70%. The somatostatin analog, angiopeptin, was similarly effective in the same circumstances. Estradiol failed to further inhibit neointimal thickening when combined with angiopeptin. Treatment with estradiol for 3 days inhibited both thymidine incorporation (p < 0.01) and DNA content in injured vessels.
CONCLUSION: Estradiol treatment of rabbits undergoing balloon injury of the aorta and iliac arteries, significantly inhibits the myointimal thickening. This effect of estrogen is mediated by inhibition of vascular smooth muscle cell proliferation.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7909339     DOI: 10.1016/s0741-5214(94)70047-8

Source DB:  PubMed          Journal:  J Vasc Surg        ISSN: 0741-5214            Impact factor:   4.268


  12 in total

1.  Estradiol attenuates directed migration of vascular smooth muscle cells in vitro.

Authors:  F D Kolodgie; A Jacob; P S Wilson; G C Carlson; A Farb; A Verma; R Virmani
Journal:  Am J Pathol       Date:  1996-03       Impact factor: 4.307

2.  Estrogen receptor alpha is a major mediator of 17beta-estradiol's atheroprotective effects on lesion size in Apoe-/- mice.

Authors:  J B Hodgin; J H Krege; R L Reddick; K S Korach; O Smithies; N Maeda
Journal:  J Clin Invest       Date:  2001-02       Impact factor: 14.808

3.  Differentiation between vasculoprotective and uterotrophic effects of ligands with different binding affinities to estrogen receptors alpha and beta.

Authors:  S Mäkelä; H Savolainen; E Aavik; M Myllärniemi; L Strauss; E Taskinen; J A Gustafsson; P Häyry
Journal:  Proc Natl Acad Sci U S A       Date:  1999-06-08       Impact factor: 11.205

4.  Anti-atherogenicity in women does not prevent restenosis after balloon angioplasty.

Authors:  T Watanabe; S Isoyama; A Nakamura; K Shirato; H Kubota; N Sekiguchi; F Sato; A Katoh; K Munakata; M Sugi; E Nozaki; O Nishioka; K Tamaki; K Akai; T Araki; K Yokoyama
Journal:  Heart Vessels       Date:  1997       Impact factor: 2.037

5.  Estrogen reduces atherosclerotic lesion development in apolipoprotein E-deficient mice.

Authors:  P A Bourassa; P M Milos; B J Gaynor; J L Breslow; R J Aiello
Journal:  Proc Natl Acad Sci U S A       Date:  1996-09-17       Impact factor: 11.205

6.  Decreased collagen and increased matrix metalloproteinase-13 in experimental abdominal aortic aneurysms in males compared with females.

Authors:  Brenda S Cho; Karen J Roelofs; John W Ford; Peter K Henke; Gilbert R Upchurch
Journal:  Surgery       Date:  2009-09-20       Impact factor: 3.982

7.  Differential regulation of aortic growth in male and female rodents is associated with AAA development.

Authors:  Brenda S Cho; Derek T Woodrum; Karen J Roelofs; James C Stanley; Peter K Henke; Gilbert R Upchurch
Journal:  J Surg Res       Date:  2008-08-27       Impact factor: 2.192

Review 8.  G-protein-coupled estrogen receptor as a new therapeutic target for treating coronary artery disease.

Authors:  Guichun Han; Richard E White
Journal:  World J Cardiol       Date:  2014-06-26

Review 9.  Estrogen receptor transcription and transactivation: Basic aspects of estrogen action.

Authors:  S Nilsson; J A Gustafsson
Journal:  Breast Cancer Res       Date:  2000-07-13       Impact factor: 6.466

10.  Activation of GPER Induces Differentiation and Inhibition of Coronary Artery Smooth Muscle Cell Proliferation.

Authors:  Fen Li; Xuan Yu; Claudia K Szynkarski; Cong Meng; Beiyan Zhou; Rola Barhoumi; Richard E White; Cristine L Heaps; John N Stallone; Guichun Han
Journal:  PLoS One       Date:  2013-06-19       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.